Your browser doesn't support javascript.
loading
The brain microvasculature is a primary mediator of interferon-α neurotoxicity in human cerebral interferonopathies.
Viengkhou, Barney; Hayashida, Emina; McGlasson, Sarah; Emelianova, Katie; Forbes, Deborah; Wiseman, Stewart; Wardlaw, Joanna; Verdillo, Rovin; Irani, Sarosh R; Duffy, Darragh; Piehl, Fredrik; Loo, Lipin; Pagenstecher, Axel; Neely, G Greg; Crow, Yanick J; Campbell, Iain L; Hunt, David P J; Hofer, Markus J.
Affiliation
  • Viengkhou B; School of Life and Environmental Sciences and the Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia.
  • Hayashida E; School of Life and Environmental Sciences and the Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia.
  • McGlasson S; UK Dementia Research Institute at University of Edinburgh, Edinburgh EH16 4SB, UK; Centre for Clinical Brain Sciences at University of Edinburgh, Edinburgh EH16 4SB, UK.
  • Emelianova K; UK Dementia Research Institute at University of Edinburgh, Edinburgh EH16 4SB, UK.
  • Forbes D; UK Dementia Research Institute at University of Edinburgh, Edinburgh EH16 4SB, UK; Centre for Clinical Brain Sciences at University of Edinburgh, Edinburgh EH16 4SB, UK.
  • Wiseman S; Centre for Clinical Brain Sciences at University of Edinburgh, Edinburgh EH16 4SB, UK.
  • Wardlaw J; UK Dementia Research Institute at University of Edinburgh, Edinburgh EH16 4SB, UK; Centre for Clinical Brain Sciences at University of Edinburgh, Edinburgh EH16 4SB, UK.
  • Verdillo R; School of Life and Environmental Sciences and the Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia.
  • Irani SR; Oxford Autoimmune Neurology Group, University of Oxford, Oxford, UK.
  • Duffy D; Translational Immunology Unit, Institut Pasteur, Université Paris Cité, Paris, France.
  • Piehl F; Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Loo L; School of Life and Environmental Sciences and the Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia.
  • Pagenstecher A; Department of Neuropathology, University of Marburg, Baldingerstrasse, 35043 Marburg, Germany.
  • Neely GG; School of Life and Environmental Sciences and the Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia.
  • Crow YJ; MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK; Laboratory of Neurogenetics and Neuroinflammation, Institut Imagine, Université de Paris, Paris, France.
  • Campbell IL; School of Life and Environmental Sciences and the Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia.
  • Hunt DPJ; UK Dementia Research Institute at University of Edinburgh, Edinburgh EH16 4SB, UK; Centre for Clinical Brain Sciences at University of Edinburgh, Edinburgh EH16 4SB, UK. Electronic address: david.hunt@ed.ac.uk.
  • Hofer MJ; School of Life and Environmental Sciences and the Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia. Electronic address: markus.hofer@sydney.edu.au.
Immunity ; 57(7): 1696-1709.e10, 2024 Jul 09.
Article in En | MEDLINE | ID: mdl-38878770

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain / Interferon-alpha / Receptor, Interferon alpha-beta / Microvessels / Nervous System Malformations Limits: Animals / Female / Humans / Male Language: En Journal: Immunity Journal subject: ALERGIA E IMUNOLOGIA Year: 2024 Document type: Article Affiliation country: Australia Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain / Interferon-alpha / Receptor, Interferon alpha-beta / Microvessels / Nervous System Malformations Limits: Animals / Female / Humans / Male Language: En Journal: Immunity Journal subject: ALERGIA E IMUNOLOGIA Year: 2024 Document type: Article Affiliation country: Australia Country of publication: Estados Unidos